Chandramouli Nagarajan MBBS, FRCP(Edin), FRCPath(UK)

Board Member

Dr. Chandramouli is a Senior Consultant Haematologist at the Department of Haematology at Singapore General Hospital and National Cancer Center Singapore and the current Head of the SingHealth Duke NUS Blood Cancer Centre.

He serves as the sub-Specialty Lead for Multiple Myeloma and Lymphoma in SGH and SingHealth-Duke NUS Blood Cancer Center. He has a passion for clinical trials and has led investigator-initiated studies in myeloma and lymphoma. He is an EHA CRTH Scholar, member and co-chair of the clinical trial sub-committee of the Asian Myeloma Network, International Myeloma Working Group, International Myeloma Society and European Research Initiative on CLL.

His other area of interest is medical education. He is an RCP accredited Educator and has served as the Programme Director for SingHealth and APD for the National Haematology Senior Residency Programme from 2018 – Jun 2023.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events